At close: December 13 at 1:30:36 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,841,919.00
3,809,262.00
4,344,948.00
3,947,903.00
3,678,969.00
Cost of Revenue
2,511,628.00
2,536,200.00
2,838,603.00
2,651,268.00
2,445,001.00
Gross Profit
1,330,291.00
1,273,062.00
1,506,345.00
1,296,635.00
1,233,968.00
Operating Expense
1,382,197.00
1,270,477.00
1,246,327.00
1,160,393.00
1,087,304.00
Operating Income
-51,906.00
2,585.00
260,018.00
136,242.00
146,664.00
Net Non Operating Interest Income Expense
-27,011.00
-22,153.00
-19,799.00
-15,781.00
-18,513.00
Pretax Income
-35,170.00
15,600.00
273,300.00
159,513.00
180,393.00
Tax Provision
3,112.00
14,944.00
56,334.00
31,981.00
26,572.00
Net Income Common Stockholders
-34,212.00
-6,665.00
170,267.00
111,374.00
135,463.00
Diluted NI Available to Com Stockholders
-34,212.00
-6,665.00
170,267.00
111,374.00
135,463.00
Basic EPS
-0.41
-0.08
2.01
1.35
1.84
Diluted EPS
-0.41
-0.08
2.00
1.32
1.83
Basic Average Shares
86,274.49
84,929.00
84,748.00
82,235.00
73,677.00
Diluted Average Shares
86,274.49
84,929.00
85,252.00
84,905.00
74,002.00
Total Expenses
3,893,825.00
3,806,677.00
4,084,930.00
3,811,661.00
3,532,305.00
Net Income from Continuing & Discontinued Operation
-34,212.00
-6,665.00
170,267.00
111,374.00
135,463.00
Normalized Income
-36,351.20
-8,175.40
171,498.30
113,064.16
134,444.88
Interest Income
3,498.00
3,217.00
3,182.00
4,049.00
3,217.00
Interest Expense
30,509.00
25,370.00
22,981.00
19,830.00
21,730.00
Net Interest Income
-27,011.00
-22,153.00
-19,799.00
-15,781.00
-18,513.00
EBIT
-4,661.00
40,970.00
296,281.00
179,343.00
202,123.00
EBITDA
317,848.00
347,118.00
580,006.00
423,764.00
430,776.00
Reconciled Cost of Revenue
2,511,628.00
2,536,200.00
2,838,603.00
2,651,268.00
2,445,001.00
Reconciled Depreciation
322,509.00
306,148.00
283,725.00
244,421.00
228,653.00
Net Income from Continuing Operation Net Minority Interest
-34,212.00
-6,665.00
170,267.00
111,374.00
135,463.00
Total Unusual Items Excluding Goodwill
2,674.00
1,888.00
-1,551.00
-2,114.00
1,194.00
Total Unusual Items
2,674.00
1,888.00
-1,551.00
-2,114.00
1,194.00
Normalized EBITDA
315,174.00
345,230.00
581,557.00
425,878.00
429,582.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
534.80
377.60
-319.70
-423.84
175.88
12/31/2020 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1781.TWO Health & Life Co., Ltd.
17.15
-3.11%
4106.TW Wellell Inc.
24.35
0.00%
4183.TWO EPS Bio Technology Corp.
22.60
-1.53%
4735.TWO AViTA Corporation
39.55
-2.83%
4161.TWO Bioptik Technology Incorporation
33.30
-1.77%
4138.TWO Dynamic Medical Technologies Inc.
91.20
-0.87%
3373.TWO Radiant Innovation Inc.
20.35
-3.55%
4129.TWO United Orthopedic Corporation
94.10
-1.36%
6649.TWO Taiwan Biomaterial Co., Ltd.
35.45
-1.25%
4188.TWO AmCad BioMed Corporation
21.70
+0.70%